BHUPINDERJIT BALLAGAN: Open Payments
NPI 1215568589 · BELTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$502 in 23 payments from 17 companies in 2025. Trend: 2023 $590 · 2024 $379 · 2025 $502
Food & beverage: $502
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 4 | $92 |
| Janssen Biotech, Inc. | 2 | $52 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $40 |
| PFIZER INC. | 2 | $31 |
| Daiichi Sankyo Inc. | 1 | $27 |
| SOBI, INC | 1 | $26 |
| Octapharma USA, Inc. | 1 | $25 |
| Astellas Pharma US Inc | 1 | $22 |
| Genentech USA, Inc. | 1 | $22 |
Products named: KEYTRUDA, ALUNBRIG, DARZALEX, Rubraca, DATROWAY, Doptelet, OCTAGAM IMMUNE GLOBULIN (HUMAN), OJJAARA.
Industry payments across MO — which companies pay providers there.
